Equities

Innovative Eyewear Inc

LUCY:NAQ

Innovative Eyewear Inc

Actions
Consumer DiscretionaryPersonal Goods
  • Price (USD)6.70
  • Today's Change-0.24 / -3.46%
  • Shares traded43.66k
  • 1 Year change-19.28%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 19:26 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Innovative Eyewear, Inc. is a developer of ChatGPT enabled smart eyewear, under the Lucyd, Nautica, Eddie Bauer and Reebok brands. The Company develops and sells smart eyeglasses and sunglasses, which are designed to allow its customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its first commercial product, Lucyd Lyte, enables the wearer to remain connected to their digital lives. Its product offering consists of 29 different models, which offers a similar amount of style variety as many traditional eyewear collections. All styles are each available with 80+ different lens types, resulting in thousands of variations of products available. The Company has over 100 licensed patents and applications. The Company’s smartglasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands-free.

  • Revenue in USD (TTM)1.53m
  • Net income in USD-7.86m
  • Incorporated2020
  • Employees11.00
  • Location
    Innovative Eyewear Inc11900 Biscayne Blvd, Ste 630MIAMI 33181United StatesUSA
  • Phone+1 (786) 910-1898
  • Fax+1 (302) 636-5454
  • Websitehttps://lucyd.co/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Bioelectronics Corp1.61m-289.82k8.65m9.00------5.37-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
Precipio Inc16.72m-3.83m9.10m51.00--0.7448--0.5444-2.68-2.6811.738.240.908917.1216.80327,843.10-20.82-44.98-27.94-58.6839.0828.80-22.90-118.070.590-192.590.0517--61.4639.6252.04--5.37--
Sigyn Therapeutics Inc0.00-3.70m9.15m5.00---------3.08-3.080.00-2.910.00----0.00-1,085.72-493.15-----------10,223.960.0247-2.09---------41.51------
T2 Biosystems Inc7.16m-48.26m9.16m113.00------1.28-10.70-10.701.09-0.33910.24352.825.4163,398.23-164.01-106.01---253.03-86.96-12.60-673.67-317.930.359-12.442.00---67.75-7.2919.66---20.19--
Applied DNA Sciences Inc3.40m-7.52m9.44m53.00--0.1554--2.78-11.86-11.862.181.200.20926.835.6864,114.15-45.51-88.57-55.20-121.9125.0444.35-217.48-113.263.76--0.00---26.4327.92-18.73--33.80--
PetVivo Holdings Inc975.28k-10.11m9.80m20.00--11.76--10.05-0.6705-0.67050.0620.04170.32570.40516.3748,764.00-337.63-230.77-589.09-467.9983.6066.21-1,036.50-1,501.440.455-1,075.050.0221--5.62---25.67--23.91--
QT Imaging Holdings Inc0.00-4.02m10.24m----0.471-----0.3999-0.39990.001.010.00-------12.32---16.60--------------0.3042-------45.07------
REMSleep Holdings Inc144.88k-1.81m10.26m6.00--17.84--70.82-0.0012-0.00120.00010.00040.081.694.75---99.82-152.40-122.32-317.98-491.08---1,246.94-2,317.521.47-43.580.1207---36.48--12.13--28.26--
Guided Therapeutics Inc38.00k-2.39m10.78m4.00------283.66-0.0444-0.04440.0007-0.08290.02110.03658.449,500.00-120.81-136.13----42.1129.39-5,721.05-3,666.670.0679-7.58----653.8511.4524.40------
Innovative Eyewear Inc1.53m-7.86m10.90m11.00--1.44--7.13-11.01-11.012.054.810.17791.9715.91139,070.90-91.45---96.06---2.46---514.10--12.85--0.00--74.67---17.28------
Golden Valley Development Inc0.00-92.53k11.63m0.00---------11.17-11.170.00-0.02110.00-------7,710.83-------------3,073.27---3.96--------45.48------
SeaStar Medical Holding Corp0.00-33.23m11.65m12.00---------21.41-21.410.00-2.140.00----0.00-1,145.80-----------------9.51---------115.19------
PAVmed Inc3.83m-67.35m11.66m107.00------3.04-8.17-8.170.4595-7.740.0823--29.4535,785.05-155.93-154.56---1,152.82-77.59---1,895.64-8,764.890.5529-8.161.74--550.40--25.76--55.51--
Autonomix Medical Inc-100.00bn-100.00bn12.21m5.00--1.93----------5.50----------------------------0.1647-------674.99------
STRATA Skin Sciences Inc32.73m-8.31m12.81m99.00--1.13--0.3913-2.37-2.379.352.710.69063.477.81330,606.10-17.54-11.48-24.26-16.5554.3061.28-25.40-17.700.9176-2.690.6141---7.752.24-95.17--23.29--
BioRegenx Inc1.29m-4.28m12.96m10.00--0.9114--10.03-0.0053-0.00530.00230.01490.1438----129,234.00-47.59---58.94--66.76---331.00--0.0533-28.810.1284---47.25---629.37------
Data as of Nov 13 2024. Currency figures normalised to Innovative Eyewear Inc's reporting currency: US Dollar USD

Institutional shareholders

1.04%Per cent of shares held by top holders
HolderShares% Held
Jane Street Capital LLCas of 30 Jun 20244.61k0.29%
Geode Capital Management LLCas of 30 Jun 20243.20k0.20%
UBS Securities LLCas of 30 Jun 20243.07k0.20%
The Vanguard Group, Inc.as of 30 Jun 20242.36k0.15%
G1 Execution Services LLCas of 30 Jun 20242.33k0.15%
Kolinsky Wealth Management LLCas of 30 Jun 2024500.000.03%
Morgan Stanley & Co. LLCas of 30 Jun 2024180.000.01%
Tower Research Capital LLCas of 30 Jun 2024111.000.01%
Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 30 Jun 202413.000.00%
Bank of America, NA (Private Banking)as of 30 Jun 20244.000.00%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.